BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17890272)

  • 1. Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.
    Bian Y; Knobloch TJ; Sadim M; Kaklamani V; Raji A; Yang GY; Weghorst CM; Pasche B
    Hum Mol Genet; 2007 Dec; 16(24):3128-35. PubMed ID: 17890272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
    Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
    BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation.
    Rosman DS; Phukan S; Huang CC; Pasche B
    Cancer Res; 2008 Mar; 68(5):1319-28. PubMed ID: 18316594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.
    Skoglund Lundin J; Vandrovcova J; Song B; Zhou X; Zelada-Hedman M; Werelius B; Houlston RS; Lindblom A
    Br J Cancer; 2009 May; 100(10):1674-9. PubMed ID: 19401691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFBR1 and cancer susceptibility.
    Pasche B; Pennison MJ; Jimenez H; Wang M
    Trans Am Clin Climatol Assoc; 2014; 125():300-12. PubMed ID: 25125747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent detection of germline allele-specific expression of TGFBR1 in lymphoblasts and tissues of colon cancer patients.
    Guda K; Natale L; Lutterbaugh J; Wiesner GL; Lewis S; Tanner SM; Tomsic J; Valle L; de la Chapelle A; Elston RC; Willis J; Markowitz SD
    Cancer Res; 2009 Jun; 69(12):4959-61. PubMed ID: 19509225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study.
    Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA
    BMC Cancer; 2010 Apr; 10():169. PubMed ID: 20429896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.
    Bian Y; Terse A; Du J; Hall B; Molinolo A; Zhang P; Chen W; Flanders KC; Gutkind JS; Wakefield LM; Kulkarni AB
    Cancer Res; 2009 Jul; 69(14):5918-26. PubMed ID: 19584284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFBR1*6A is a potential modifier of migration and invasion in colorectal cancer cells.
    Zhou R; Huang Y; Cheng B; Wang Y; Xiong B
    Oncol Lett; 2018 Mar; 15(3):3971-3976. PubMed ID: 29467907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No major association between TGFBR1*6A and prostate cancer.
    Kaklamani V; Baddi L; Rosman D; Liu J; Ellis N; Oddoux C; Ostrer H; Chen Y; Ahsan H; Offit K; Pasche B
    BMC Genet; 2004 Sep; 5():28. PubMed ID: 15385056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.
    Liao RY; Mao C; Qiu LX; Ding H; Chen Q; Pan HF
    Mol Biol Rep; 2010 Oct; 37(7):3227-32. PubMed ID: 19882361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.
    Pasche B; Wisinski KB; Sadim M; Kaklamani V; Pennison MJ; Zeng Q; Bellam N; Zimmerman J; Yi N; Zhang K; Baron J; Stram DO; Hayes MG
    J Exp Clin Cancer Res; 2010 May; 29(1):57. PubMed ID: 20500843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
    Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
    Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.
    Chen T; Yan W; Wells RG; Rimm DL; McNiff J; Leffell D; Reiss M
    Int J Cancer; 2001 Sep; 93(5):653-61. PubMed ID: 11477574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.
    Dutt SS; Chen N; Darbary HK; Swede H; Petrelli NJ; Stoler DL; Anderson GR
    Mutat Res; 2008 Oct; 645(1-2):27-32. PubMed ID: 18778720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta signaling alterations and susceptibility to colorectal cancer.
    Xu Y; Pasche B
    Hum Mol Genet; 2007 Apr; 16 Spec No 1(SPEC):R14-20. PubMed ID: 17613544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.